We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > CD3

News List

Boan Biotech Publishes Research Results for CEA/CD3 Bispecific Antibody in Antibody Therapeutics prnasia
June 25, 2021
Luye Pharma Group's subsidiary Boan Biotech recently published research results for its innovative in-house bispecific antibody BA1202 (CEA/CD3 bispecific T-cell engager) in Antibody Therapeutics.
Lilly and Merus partner to develop T-Cell re-directing antibody therapies pharmaceutical-technology
January 21, 2021
Research and development group of Eli Lilly and Company, Loxo Oncology at Lilly, and clinical-stage oncology company Merus have announced a research collaboration and exclusive license agreement to develop T-Cell re-directing bispecific antibodies.